Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial. (Q51001464)
Jump to navigation
Jump to search
scientific article published on 23 November 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial. |
scientific article published on 23 November 2016 |
Statements
Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial (English)
Oliver Gautschi
Sacha I Rothschild
Qiyu Li
Klazien Matter-Walstra
Alfred Zippelius
Daniel C Betticher
Martin Früh
Rolf A Stahel
Richard Cathomas
Daniel Rauch
Miklos Pless
Solange Peters
Patrizia Froesch
Thilo Zander
Martina Schneider
Christine Biaggi
Nicolas Mach
Swiss Group for Clinical Cancer Research